Business
Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease
SAN DIEGO, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients
About this update from Exagen Inc.
[{"type":"text","content":"SAN DIEGO, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that it has entered into a strategic partnership with Sonora Quest, the nation’s largest integrated laboratory system. The agreement provides preferred access through Sonora Quest in Arizona to Exagen’s AVISE testing. The testing can facilitate improved care through the differential diagnosis, prognosis, monitoring and therapeutic optimization of complex and incurable autoimmune rheumatic diseases. The details of the agreement are confidential.\n “We’re pleased to be working with Sonora Quest in a shared commitment to improve patients’ lives. Expanding access to our portfolio of innovative products will have a significant impact on patients, enabling rheumatologists to improve patient care through insights available exclusively through our patented technology,” said Ron Rocca, President and CEO of Exagen. “This is an important step towards helping the estimated 23 million Americans who are yet to be accurately diagnosed for conditions that can present with symptoms similar to lupus or rheumatoid arthritis.” “The AVISE tests add tremendous value to our continually expanding menu of testing, providing consumers in Arizona more power to proactively manage their health through access to innovative testing platforms,” said Christina Noble, Chief Growth Officer at Sonora Quest Laboratories. “Lupus is known for being difficult to diagnose because its symptoms differ from person to person, mimic the symptoms of many other diseases, and can come and go. A Lupus Foundation of America survey found that on average, it takes nearly six years for people with lupus to be diagnosed, and this partnership seeks to reduce that delay.” AVISE testing will be available through healthcare provider customers of Sonora Quest beginning in spring 2020. Healthcare providers and patients and their families can find more information about this testing at www.avisetest.com and can expect to see additional information on www.SonoraQuest.com in the coming weeks. About Autoimmune Rheumatic Diseases Autoimmune rheumatic diseases are a diverse group of conditi...